FindTrial
Sign In

To compare the effect of Varmam therapy and vasavennai oil for shoulder joint degeneration

A comparative clinical trial of effectiveness of Varmam therapy and Vasavennai (externally) on Kumbavatham (Periarthritis shoulder) - VTVK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020731
Enrollment
45
Registered
2019-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Control Intervention1: exclusively Varmam therapy and vasavennai: Compare three groups Group A Varmam Group B vasavennai(external application) Group C Varmam and vasavennai(External) Route of administ

Sponsors

Dr Vrindha KV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pain and stiffness in shoulder joint Restricted movements of shoulder joint(abduction and external rotation) Exacerbation of pain on movements With or without pain radiating to arm Patient willing to undergo radiological investigation and give blood samples for laboratory investigations

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Septic arthritis Malignant hypertension Psoriatic arthritis Rheumatoid arthritis Gonococcal arthritis Fracture and dislocations of shoulder joint Any other systemic and chronic illness

Design outcomes

Primary

MeasureTime frame
To evaluate the therapeutic efficacy of Varmam therapy and Vasavennai in the treatment of kumbavathamTimepoint: 6 months—

Secondary

MeasureTime frame
To standardize the therapeutic efficacy of Varmam in the treatment of kumbavatham To observe the co morbid conditions occur in kumbavatham (periarthritis shoulder) Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr R Varsha Noble

National Institute of Siddha

njmuthu@hotmail.com9962006843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026